Insmed (INSM) Change in Receivables (2010 - 2026)

Insmed has reported Change in Receivables for 12 years, with the latest figure at $37.2 million in Q2 2026.

• On a quarterly basis, Change in Receivables rose 505.01% year-over-year to $37.2 million in Q2 2026; TTM through Jun 2026 was $162.9 million, a 1189.29% increase from a year earlier, with the FY2025 full-year figure at $88.3 million, up 582.86% from the prior year.
• Change in Receivables was $37.2 million for Q2 2026 at Insmed, down from $38.2 million in the prior quarter.
• The five-year high for Change in Receivables was $77.3 million in Q4 2025, with the low at -$5.4 million in Q1 2025.
• Average Change in Receivables over 5 years is $10.8 million, with a median of $4.3 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Receivables slumped 443.6% in 2024, then surged 29117.14% in 2025.
• Over 5 years, Change in Receivables stood at $983000.0 in 2022, then jumped by 361.34% to $4.5 million in 2023, then surged by 160.57% to $11.8 million in 2024, then surged by 554.14% to $77.3 million in 2025, then plunged by 51.93% to $37.2 million in 2026.
• The last three Change in Receivables figures came in at $37.2 million (Q2 2026), $38.2 million (Q1 2026), and $77.3 million (Q4 2025), per Business Quant data.